HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xavier Chevalier Selected Research

hylan

1/2020Efficacy and Safety of Hylan G-F 20 Versus Intra-Articular Corticosteroids in People with Knee Osteoarthritis: A Systematic Review and Network Meta-Analysis.
7/2008Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis.
5/2008Comparison of hylan and hyaluronic acid for knee osteoarthritis: comment on the article by Jüni et al.
12/2006Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xavier Chevalier Research Topics

Disease

24Knee Osteoarthritis
12/2021 - 07/2005
23Osteoarthritis
07/2021 - 03/2005
18Pain (Aches)
12/2021 - 01/2005
5Rheumatoid Arthritis
07/2013 - 11/2004
4Hip Osteoarthritis (Coxarthrosis)
12/2021 - 12/2006
3Obesity
08/2019 - 10/2017
3Inflammation (Inflammations)
11/2016 - 11/2009
3Joint Diseases (Joint Disease)
07/2013 - 01/2004
3Spondylarthropathies
01/2012 - 11/2005
2Weight Loss (Weight Reduction)
05/2019 - 01/2011
2Disease Progression
01/2018 - 10/2006
2Synovitis
11/2016 - 11/2010
2Infections
07/2015 - 01/2004
2Osteoporosis
02/2013 - 02/2012
2Psoriasis (Pustulosis Palmaris et Plantaris)
05/2012 - 02/2007
2Psoriatic Arthritis
01/2009 - 11/2005
2Ankylosing Spondylitis
02/2007 - 11/2005
1Neuralgia (Stump Neuralgia)
12/2021
1Bites and Stings (Sting)
12/2021
1Pruritus (Itching)
12/2021
1Hypesthesia (Numbness)
12/2021
1Metabolic Bone Diseases (Osteopenia)
01/2021
1Secondary Hyperparathyroidism
01/2021
1Metabolic Diseases (Metabolic Disease)
01/2021
1Vitamin D Deficiency
01/2021
1Fever (Fevers)
01/2020
1Discitis
01/2020
1Overweight
01/2020
1Cardiovascular Diseases (Cardiovascular Disease)
10/2018
1Hypertension (High Blood Pressure)
10/2018
1Type 2 Diabetes Mellitus (MODY)
10/2018
1Fibrosis (Cirrhosis)
06/2017
1Necrosis
11/2016
1Hemolytic Anemia
07/2015
1Tendinopathy (Tendonitis)
07/2015
1Atrial Fibrillation
05/2013
1Compression Fractures (Compression Fracture)
05/2013
1Pulmonary Embolism
05/2013
1Aortic Aneurysm (Aneurysm, Aortic)
04/2012
1Sepsis (Septicemia)
04/2012
1Spine Osteoarthritis
02/2012

Drug/Important Bio-Agent (IBA)

17Hyaluronic Acid (Hyaluronan)IBA
12/2021 - 05/2008
7Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2005
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2012 - 01/2004
4hylanIBA
01/2020 - 12/2006
4Pharmaceutical PreparationsIBA
12/2012 - 07/2008
4Interleukin-1 (Interleukin 1)IBA
08/2011 - 07/2005
4CytokinesIBA
11/2010 - 11/2004
4Infliximab (Remicade)FDA Link
06/2008 - 01/2004
3Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021 - 07/2015
3C-Reactive ProteinIBA
01/2020 - 01/2011
3Interleukin-6 (Interleukin 6)IBA
06/2017 - 11/2009
3Etanercept (Enbrel)FDA Link
01/2009 - 11/2005
2Prostaglandins AIBA
12/2021 - 01/2017
24-hexyloxyaniline (HOA)IBA
07/2021 - 01/2017
2Analgesics (Analgesic Drugs)IBA
01/2021 - 10/2016
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2020 - 01/2005
2Mannitol (Osmitrol)FDA LinkGeneric
01/2017 - 10/2016
2CollagenIBA
11/2016 - 01/2011
2Cartilage Oligomeric Matrix ProteinIBA
11/2016 - 01/2011
2strontium ranelate (protelos)IBA
02/2013 - 02/2012
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
08/2011 - 07/2005
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2021
1tocilizumab (atlizumab)FDA Link
01/2021
1CalciumIBA
01/2021
1Phosphorus (Red Phosphorus)IBA
01/2021
1Duloxetine Hydrochloride (Cymbalta)FDA Link
12/2020
1Opioid Analgesics (Opioids)IBA
12/2020
1Acetaminophen (Paracetamol)FDA LinkGeneric
12/2020
1LipidsIBA
10/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2018
1Dinoprostone (PGE2)FDA Link
06/2017
1von Willebrand FactorIBA
06/2017
1Interleukin-8 (Interleukin 8)IBA
06/2017
1Tryptases (Tryptase)IBA
06/2017
1Collagen Type II (Type II Collagen)IBA
01/2017
1Saline SolutionIBA
01/2017
1InterleukinsIBA
11/2016
1ViscosupplementsIBA
10/2016
1Viral AntibodiesIBA
07/2015
1Immunoglobulin M (IgM)IBA
07/2015
1DNA (Deoxyribonucleic Acid)IBA
07/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2015
1Nerve Growth Factor (NGF)IBA
07/2013
1Biological ProductsIBA
07/2013
1Rituximab (Mabthera)FDA Link
05/2012
1Abatacept (Orencia)FDA Link
01/2012
1RezafunginIBA
03/2011

Therapy/Procedure

12Viscosupplementation
12/2021 - 07/2008
11Therapeutics
01/2020 - 01/2004
8Intra-Articular Injections
01/2017 - 07/2005
6Injections
12/2021 - 12/2006
2Retreatment
12/2021 - 01/2018
1Off-Label Use
12/2020
1Contraindications
01/2020
1Braces
05/2019
1Orthotic Devices (Orthosis)
05/2019
1Vertebroplasty
05/2013
1Punctures
05/2013
1Tracheostomy
04/2012